Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832152 | 12583215 | 2 | F | 20160711 | 20160728 | 20160722 | 20160803 | EXP | NL-AMGEN-NLDSL2016093863 | AMGEN | 72.00 | YR | E | F | Y | 0.00000 | 20160803 | MD | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832152 | 12583215 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 0.6 ML, Q2WK (10 MG/ML WWSP 0.6ML, 1.00 X PER 2 WEKEN) | U | 125031 | .6 | ML | SOLUTION FOR INJECTION | QOW | |||||
| 125832152 | 12583215 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | 20 MG, UNK | U | 125031 | 20 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125832152 | 12583215 | 1 | Prophylaxis |
| 125832152 | 12583215 | 2 | Neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125832152 | 12583215 | HO |
| 125832152 | 12583215 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125832152 | 12583215 | Intentional product misuse | |
| 125832152 | 12583215 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |